Remoteness of residence predicts tumor stage, receipt of treatment, and mortality in patients with hepatocellular carcinoma.

Patients living in rural and remote areas had late stage clinical presentation and poor survival. Remoteness of residence may limit access to HCC surveillance in at-risk patients such as those with cirrhosis, and timely curative treatment to improve survival in these patients.